SCOTUS justices must step up on software patents

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

SCOTUS justices must step up on software patents

Few topics in IP have proved as divisive and difficult in the past 20 years as patent protection for software. A sensible decision from the US Supreme Court in the Alice v CLS Bank case could help to bring peace

Contributions to the debate on whether or not patents should be granted for software are strongly felt, well argued and can become emotional. When the EU was debating the CII Directive, one MEP told me she had received more hate mail regarding software patents than on any other topic during her term.

The outcome of that debate, as many readers will remember, was that the Parliament overwhelmingly rejected the Directive and it was dropped. As far as European patents are concerned, computer programs “as such” remain unpatentable.

By contrast, the US has laid out the red carpet for software and business method patents, at least since the Federal Circuit’s State St decision in 1998 which gave us the “useful, concrete and tangible result” test. The 15 years after that coincided with the explosion of the internet and e-commerce, and the liberal approach to software patentability contributed to the continual growth in filings at the USPTO.

Put crudely, it was US = good, Europe = bad for software patents (unless you were an unbeliever, in which case it was Europe = good, US = bad).

But that simple distinction no longer stands. In Europe, the law is predictable and patent attorneys will tell you that a good invention, with a cleverly worded set of claims, can still get protection at the EPO. The data support this: the EPO grants about 2500 software patents annually. Even courts, such as those in the UK, that were robust in rejecting software patents, have softened. In the US, though, following the Supreme Court’s curious decision in Bilski v Kappos and the Federal Circuit’s split over CLS Bank v Alice, there is considerable uncertainty. (This was clear in two webinars we held last year, both of which you can still listen to – Software Patenting in Europe and Software patents after CLS Bank.)

In our latest issue, we published a survey of approaches to software patents in five jurisdictions (Australia, China, India, the US and the EPO). Each contribution addressed five questions about the patentability of software and strategies for protection. Gareth Fennell and Rob Genders, writing on Europe, say that EPO practice is “relatively settled” and it is a myth that the Office does not grant software patents. But John Collins, of Schwegman Lundberg Woessner, notes that the US is “arrived at a point of confusion and uncertainty”.

The diversity of approaches increases the further afield you look. Last week, Marks & Clerk published a preview of their High-Tech Report 2014, which provides data and analysis on software patents in the EPO, the UK, Germany, France, the US, Canada, China, Asean, Singapore, Australia and New Zealand. Mark Kenrick, a partner of the firm and one of the report’s authors, told me: “The inconsistency in this area is a problem. It leads to misunderstandings about what can and cannot be patented.”

The almost-theological divide between software patent believers and atheists will probably never be bridged, and it would be naive to hope for an international agreement. But a clear and well-reasoned decision from the Supreme Court in the Alice case could go some way towards reconciling those of different views. I know some observers are not optimistic, but let’s hope that, after previously ducking the issue, the justices will this time be up to the task.

more from across site and SHARED ros bottom lb

More from across our site

AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Gift this article